Shares of NIOX Group Plc (LON:NIOX – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 56.65 ($0.73) and last traded at GBX 65.89 ($0.85), with a volume of 4448223 shares trading hands. The stock had previously closed at GBX 62.80 ($0.81).
NIOX Group Price Performance
The stock has a market capitalization of £26.53 billion, a P/E ratio of 2,665.93 and a beta of 0.92. The business has a fifty day simple moving average of GBX 61.67 and a 200 day simple moving average of GBX 63.83. The company has a current ratio of 6.31, a quick ratio of 1.94 and a debt-to-equity ratio of 1.10.
Insider Buying and Selling
In other news, insider Jonathan Emms purchased 31,604 shares of the company’s stock in a transaction that occurred on Wednesday, December 18th. The shares were bought at an average cost of GBX 63 ($0.81) per share, with a total value of £19,910.52 ($25,664.50). 46.72% of the stock is currently owned by corporate insiders.
About NIOX Group
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
Read More
- Five stocks we like better than NIOX Group
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Investing in Commodities: What Are They? How to Invest in Them
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- The Role Economic Reports Play in a Successful Investment Strategy
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.